Cyanotech Co. (OTCMKTS:CYAN – Get Free Report) was the target of a significant decline in short interest in the month of August. As of August 31st, there was short interest totaling 653 shares, a decline of 85.0% from the August 15th total of 4,353 shares. Based on an average daily volume of 14,470 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company’s shares are sold short.
Cyanotech Trading Down 4.4%
OTCMKTS:CYAN opened at $0.49 on Friday. The company has a current ratio of 1.06, a quick ratio of 0.39 and a debt-to-equity ratio of 0.13. Cyanotech has a 1-year low of $0.23 and a 1-year high of $0.57. The firm has a market capitalization of $3.52 million, a price-to-earnings ratio of -1.94 and a beta of 0.07. The business’s 50-day moving average price is $0.50 and its two-hundred day moving average price is $0.44.
Cyanotech (OTCMKTS:CYAN – Get Free Report) last announced its quarterly earnings results on Monday, June 29th. The biotechnology company reported $0.00 EPS for the quarter. Cyanotech had a negative return on equity of 0.86% and a negative net margin of 0.25%.
Cyanotech Company Profile
Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids.
See Also
- Five stocks we like better than Cyanotech
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.
